Ayalon Insurance Company’s Pfizer PFE Stock Holding History

Ayalon Insurance Company’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-6,000	Closed	-$311K	–	132
2022 Q1	$311K	Sell	6,000 -22,715	-79%	-$1.18M	0.11%	98
2021 Q4	$1.7M	Buy	28,715 +22,715	+379%	+$1.13M	0.58%	49
2021 Q3	$258K	Hold	6,000	–	–	0.09%	95
2021 Q2	$237K	Hold	6,000	–	–	0.08%	110
2021 Q1	$218K	Sell	6,000 -19,400	-76%	-$689K	0.09%	95
2020 Q4	$935K	Buy	+25,400	New	+$932K	0.42%	58
2016 Q4	$342K	Hold	11,099	–	–	0.29%	32
2016 Q3	$357K	Hold	11,099	–	–	0.3%	33
2016 Q2	$374K	Hold	11,099	–	–	0.32%	38
2016 Q1	$316K	Sell	11,099 -10,540	-49%	-$301K	0.27%	46
2015 Q4	$663K	Hold	21,639	–	–	0.56%	40
2015 Q3	$677K	Buy	21,639 +284	+1%	+$9.11K	0.56%	35
2015 Q2	$683K	Hold	21,355	–	–	0.49%	39
2015 Q1	$705K	Buy	+21,355	New	+$679K	0.43%	50

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Ayalon Insurance Company's PFE Position: Q2 2022 in Review

Ayalon Insurance Company sold out of Pfizer (PFE) in Q2 2022, closing a stake of 6,000 shares — an estimated $311K sold.

Ayalon Insurance Company first reported a position in PFE in Q1 2015 and held it in 14 quarters. The position peaked at $1.7M in Q4 2021. 3,157 funds tracked by Wall St. Rank hold PFE as of Q2 2022.

Ayalon Insurance Company reported no remaining Pfizer position as of Q2 2022 after selling out during the quarter.
Ayalon Insurance Company sold 6,000 Pfizer shares in Q2 2022, an estimated $311K.
Ayalon Insurance Company first reported a position in Pfizer in Q1 2015 and held it in 14 quarters.
Ayalon Insurance Company's Pfizer position peaked at $1.7M in Q4 2021.
3,157 funds tracked by Wall St. Rank held Pfizer as of Q2 2022.

Based on Ayalon Insurance Company's 13F filing for Q2 2022, filed 12 Jul 2022.